MarrOwStim™ PAD Kit for the Treatment of Critical LimB IschemIa (CLI) in Subjects With Severe Peripheral ArteriaL DiseasE (PAD) (MOBILE) - Continued Access
Status: No_longer_available
Location: See all (9) locations...
Intervention Type: Device
Study Type: Expanded_access
SUMMARY
This study will continue to evaluate the performance of the MarrowStim™ PAD Kit to treat subjects with critical limb ischemia (CLI) caused by severe PAD.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
View:
• Unilateral or bilateral lower extremity ischemia due to advanced peripheral arterial disease
• Unsuitable for revascularization
• Minor tissue loss (Rutherford Category 5) or ischemic rest pain (Rutherford Category 4)
• Competent to give consent
• No current malignancy or history of previous malignancy within the last five years, with the exception of adequately treated non-melanoma skin cancer (evidence of standard preventative cancer screenings required)
Locations
United States
Arkansas
Central Arkansas Veterans Healthcare System
Little Rock
Georgia
Piedmont Hospital
Atlanta
Indiana
Indiana University
Indianapolis
Massachusetts
Tufts Medical Center
Boston
New Jersey
Holy Name Medical Center
Teaneck
New York
The Mount Sinai Hospital
New York
Weill Cornell Medical College/New York Presbyterian Hospital
New York
Ohio
Cleveland Clinic
Cleveland
Pennsylvania
VA Pittsburgh Healthcare System
Pittsburgh
Authors
Michael Murphy, Rebecca Kelso, John Rundback, Edith Tzeng, Mark Iafrati, Eric Peden, John Laird, Peter Connolly, Ageliki Vouyouka, Mohammed Moursi
Related Therapeutic Areas
Sponsors
Leads: Zimmer Biomet